Research Associate II, Oligonucleotide Synthesis
CRISPR Therapeutics
- South Boston, United States
- $85K – $92K /yr
- Entry Level
- 2+ years
- Posted
Skills
Required
- oligonucleotide synthesis
- Biochemistry
- Chemical Biology
- solid-phase
- automated synthesizer
- deprotection
- workup
- preparative HPLC purification
- analytical HPLC / LC-MS data
- bioconjugation chemistry
- NHS ester / maleimide–thiol / click chemistry
Preferred
- siRNA
- ASO
- phosphorothioate
- 2′-modified nucleotides
- antibody handling
- DAR
- protein purification platforms
- FPLC
Summary We are seeking a hands-on Research Associate II to support the synthesis, purification, and conjugation of oligonucleotides for our gene editing and targeted delivery programs. In this role you will run solid-phase oligonucleotide synthesis on automated platforms, purify and characterize crude material to research-grade specifications, and prepare small molecule–oligonucleotide and antibody–oligonucleotide conjugates that enable tissue-targeted delivery. This is a bench-intensive position within a fast-moving discovery chemistry group. You will work under the guidance of senior scientists to execute defined experimental plans with high quality and throughput, while progressively taking ownership of your own syntheses, purification campaigns, and conjugation reactions.
About CRISPR Therapeutics
Company Overview Founded over a decade ago, CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases.
The Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world’s first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia.
CRISPR Therapeutics is advancing a broad and diversified pipeline across hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative medicine and rare diseases.
The Company continues to expand its leadership in gene editing through the development of SyNTase™ editing, a novel and proprietary gene-editing platform designed to enable precise, efficient, and scalable gene correction.
To accelerate and expand its impact, CRISPR Therapeutics has established strategic collaborations with leading biopharmaceutical partners, including Vertex Pharmaceuticals.
CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Incorporate chemically modified building blocks (i.e. 2′-OMe, 2′-F) phosphorothioate and other backbone modifications, and 5′/3′ functional handles for downstream conjugation.
Ownership mindset. Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.
Responsibilities
- Success in this role means reliable, well-documented material delivered on time to in vitro and in vivo study teams.
- Oligonucleotide Synthesis Solid-phase synthesis: Execute phosphoramidite-based synthesis of chemically modified RNA/DNA on automated synthesizers at scales from micromole to millimole.
- Perform cleavage from support, base and 2′-silyl deprotection, desalting, and lyophilization using established protocols.
- Prepare amidite and reagent solutions, maintain synthesizer uptime through routine maintenance and troubleshooting, and manage consumable and raw material inventory.
- Purify crude oligonucleotides by RP-HPLC, IEX-HPLC; pool, desalt, concentrate, and formulate final material to target concentration and buffer.
- Assess identity and purity by LC-MS, UPLC, and UV quantification; interpret chromatograms and deconvoluted mass data
- Small Molecule and Antibody Conjugation Conjugate preparation: Prepare small molecule–oligonucleotide conjugates, such as GalNAc, lipid, and peptide conjugates, and support preparation of antibody–oligonucleotide conjugates using standard bioconjugation chemistries.
- Purify conjugates by chromatography and filtration, and assess purity, conjugation efficiency, and drug-to-antibody ratio.
- Run small-scale screens of reaction conditions and summarize results for the team.
- Maintain complete, contemporaneous electronic lab notebook records and accurate sample registration and inventory in the compound and reagent management systems.
- Analyze and present data clearly at team and project meetings.
- Work in accordance with all EHS requirements, including safe handling of organic solvents and reactive reagents, proper waste disposal, and correct use of fume hoods and personal protective equipment.
Requirements
- BS in Chemistry, Biochemistry, Chemical Biology, or a related discipline with 2+ years of relevant laboratory experience; or MS in a related discipline with 0–2+ years of experience.
- Hands-on experience with solid-phase oligonucleotide synthesis on an automated synthesizer, including cleavage, deprotection, and workup.
- Demonstrated experience with preparative HPLC purification and interpretation of analytical HPLC or LC-MS data.
- Practical experience with at least one bioconjugation chemistry, such as NHS ester, maleimide–thiol, or click chemistry, applied to oligonucleotides, peptides, or proteins.
- Strong general wet-chemistry experience, including accurate weighing, solution preparation, air- and moisture-sensitive handling, and anhydrous techniques.
- Meticulous documentation habits and comfort working in an electronic lab notebook.
- Ability to manage multiple parallel experiments and deliver against timelines in a fast-paced environment.
- Collaborative – Openness, One Team Undaunted – Fearless, Can-do attitude Results Orientation – Delivering progress toward our mission.
- Sense of urgency in solving problems.
- Entrepreneurial Spirit – Proactive.
Preferred
- Qualifications Experience synthesizing chemically modified siRNA, ASO, or guide RNA with phosphorothioate and 2′-modified nucleotides.
- Experience preparing GalNAc, lipid, or peptide conjugates for targeted nucleic acid delivery.
- Experience with antibody handling and antibody–drug or antibody–oligonucleotide conjugate preparation and characterization, including DAR determination.
- Familiarity with protein purification platforms such as FPLC, SEC, HIC, and TFF.
- Experience with LC-MS deconvolution software and chromatography data systems such as Empower, Chromeleon, or Unicorn.
- Exposure to design of experiments or structured screening approaches for reaction optimization.
- Experience supporting material transfer to external vendors or CDMOs.
Research Associate II
Base pay range of $85,000 to $92,000+ bonus, equity and benefits CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy
